Madrigal Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Madrigal Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDGL

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. 

CEO
William J. Sibold
CEOWilliam J. Sibold
Employees
915
Employees915
Headquarters
West Conshohocken, Pennsylvania
HeadquartersWest Conshohocken, Pennsylvania
Founded
2000
Founded2000
Employees
915
Employees915

MDGL Key Statistics

Market cap
9.92B
Market cap9.92B
Price-Earnings ratio
-71.52
Price-Earnings ratio-71.52
Dividend yield
—
Dividend yield—
Average volume
889.45K
Average volume889.45K
High today
$428.90
High today$428.90
Low today
$414.16
Low today$414.16
Open price
$424.92
Open price$424.92
Volume
434.78K
Volume434.78K
52 Week high
$615.00
52 Week high$615.00
52 Week low
$353.54
52 Week low$353.54

Stock Snapshot

The current Madrigal Pharmaceuticals(MDGL) stock price is $427.39, with a market capitalization of 9.92B. The stock trades at a price-to-earnings (P/E) ratio of -71.52.

During the trading session on 2026-11-15, Madrigal Pharmaceuticals(MDGL) shares reached a daily high of $428.90 and a low of $414.16. At a current price of $427.39, the stock is +3.2% higher than the low and still -0.4% under the high.

Trading volume for Madrigal Pharmaceuticals(MDGL) stock has reached 434.78K, versus its average volume of 889.45K.

The stock's 52-week range extends from a low of $353.54 to a high of $615.00.

The stock's 52-week range extends from a low of $353.54 to a high of $615.00.

MDGL News

TipRanks 4h
Madrigal Earnings Call Highlights Rezdiffra Growth - TipRanks

...

Madrigal Earnings Call Highlights Rezdiffra Growth - TipRanks
Simply Wall St 1d
Madrigal Pharmaceuticals Stock May Trade At A Discount As Whistleblower Claims Surface

has produced very strong long term returns, and recent headlines around its liver drug Rezdiffra and related whistleblower allegations have pushed the valuation...

Madrigal Pharmaceuticals Stock May Trade At A Discount As Whistleblower Claims Surface

Analyst ratings

95%

of 22 ratings
Buy
95.5%
Hold
4.5%
Sell
0%

People also own

Based on the portfolios of people who own MDGL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.